Back

Robigo and Leaps by Bayer announce Series A financing for engineered biologicals

Verifying
  • Robigo and Leaps by Bayer announced Series A financing for engineered biologicals.
  • The financing targets technologies intended to protect yields and reduce costs.
  • The announcement does not disclose the financing amount or further transaction details.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.